Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results

詳細情報 詳細情報について

• CRID

  1362825895864556928

• DOI

  10.1038/leu.2017.247

• ISSN

  14765551

  08876924

• Web Site

  http://www.nature.com/articles/leu2017247.pdf

  http://www.nature.com/articles/leu2017247

  http://www.nature.com/doifinder/10.1038/leu.2017.247

• データソース種別

  • Crossref